Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Spector

Showing results (171-180 of 196) with videos related to

Pageof 20
Sort By:
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
The effect of zidovudine treatment on serum neopterin and beta 2-microglobulin levels in mildly symptomatic, HIV type 1 seropositive individualsH Z Bass, W D Hardy, R T Mitsuyasu, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complexA W Wu, W C Mathews, L T Brysk, et al.
The New England Journal of Medicine|October 11, 1990
A pilot study of low-dose zidovudine in human immunodeficiency virus infectionA C Collier, S Bozzette, R W Coombs, et al.
Antiviral Research|November 1, 1996
Summary of the International Consensus Symposium on Advances in the Diagnosis, Treatment and Prophylaxis and Cytomegalovirus InfectionJ T van der Meer, W L Drew, R A Bowden, et al.
Journal of Acquired Immune Deficiency Syndromes|May 1, 1993
Functional status and well-being in a placebo-controlled trial of zidovudine in early symptomatic HIV infectionA W Wu, H R Rubin, W C Mathews, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1992
Incidence of AIDS dementia in a two-year follow-up of AIDS and ARC patients on an initial phase II AZT placebo-controlled study: San Diego cohortJ J Day, I Grant, J H Atkinson, et al.
Parkinsonism & Related Disorders|October 1, 1996
Prevalence of tremor and Parkinson's diseaseA S Khatter, M C Kurth, M A Brewer, et al.
The New England Journal of Medicine|June 6, 1996
Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study GroupS A Spector, G F McKinley, J P Lalezari, et al.
Clinical Pharmacology and Therapeutics|July 14, 2001
Population pharmacokinetics of dapsone in children with human immunodeficiency virus infectionM Mirochnick, E Cooper, E Capparelli, et al.
Annals of Neurology|January 13, 2000
Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic ParalysisR Tawil, M P McDermott, R Brown, et al.
Pageof 20

Showing results (171-180 of 196) with videos related to

Sort By:
Pageof 20
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
The effect of zidovudine treatment on serum neopterin and beta 2-microglobulin levels in mildly symptomatic, HIV type 1 seropositive individualsH Z Bass, W D Hardy, R T Mitsuyasu, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complexA W Wu, W C Mathews, L T Brysk, et al.
The New England Journal of Medicine|October 11, 1990
A pilot study of low-dose zidovudine in human immunodeficiency virus infectionA C Collier, S Bozzette, R W Coombs, et al.
Antiviral Research|November 1, 1996
Summary of the International Consensus Symposium on Advances in the Diagnosis, Treatment and Prophylaxis and Cytomegalovirus InfectionJ T van der Meer, W L Drew, R A Bowden, et al.
Journal of Acquired Immune Deficiency Syndromes|May 1, 1993
Functional status and well-being in a placebo-controlled trial of zidovudine in early symptomatic HIV infectionA W Wu, H R Rubin, W C Mathews, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1992
Incidence of AIDS dementia in a two-year follow-up of AIDS and ARC patients on an initial phase II AZT placebo-controlled study: San Diego cohortJ J Day, I Grant, J H Atkinson, et al.
Parkinsonism & Related Disorders|October 1, 1996
Prevalence of tremor and Parkinson's diseaseA S Khatter, M C Kurth, M A Brewer, et al.
The New England Journal of Medicine|June 6, 1996
Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study GroupS A Spector, G F McKinley, J P Lalezari, et al.
Clinical Pharmacology and Therapeutics|July 14, 2001
Population pharmacokinetics of dapsone in children with human immunodeficiency virus infectionM Mirochnick, E Cooper, E Capparelli, et al.
Annals of Neurology|January 13, 2000
Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic ParalysisR Tawil, M P McDermott, R Brown, et al.
Pageof 20